The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chronic Phase Marker Market Research Report 2025
Synopsis
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient’s body.
The global Chronic Phase Marker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Phase Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Phase Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chronic Phase Marker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chronic Phase Marker include Nordic BioSite, DiaSorin, Roche, Bristol-Myers Squibb, Hologic, QIAGEN, Philips, Johnson & Johnson and Lifesign, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Phase Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Phase Marker.
Report Scope
The Chronic Phase Marker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Phase Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Phase Marker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope
Segment by Type
Tumor Markers
Cardiac Markers
Thyroid Markers
Others
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Phase Marker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Markers are broadly categorized as biomarkers or molecular markers and biochemical markers. Biomarker, also known as biological marker is commonly used to carry out detection of living organism which acts as a causative agent for specific diseases. It usually refers to a measurable indicator for various biological states or disease conditions in the human body. Biomarker is any substance that can be utilized as an indicator of specific disease condition and is often evaluated to detect pathogenic processes, normal biological process, or pharmacologic response to medical treatment. The elevated levels or absence of these biological markers may indicate the onset or late stage of a chronic disease. However, chronic phase indicates early stages of chronic leukemia which is a type of cancer in white blood cells. It constitutes high amounts of abnormal white blood cells in bone marrow and blood. Chronic phase markers are the biomarkers that help in detection of a disease condition with the presence of their elevated levels in patient’s body.
The global Chronic Phase Marker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Chronic Phase Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Phase Marker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Chronic Phase Marker in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Chronic Phase Marker include Nordic BioSite, DiaSorin, Roche, Bristol-Myers Squibb, Hologic, QIAGEN, Philips, Johnson & Johnson and Lifesign, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Chronic Phase Marker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Phase Marker.
Report Scope
The Chronic Phase Marker market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Chronic Phase Marker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Chronic Phase Marker companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Nordic BioSite
DiaSorin
Roche
Bristol-Myers Squibb
Hologic
QIAGEN
Philips
Johnson & Johnson
Lifesign
Natus
BrainScope
Segment by Type
Tumor Markers
Cardiac Markers
Thyroid Markers
Others
Segment by Application
Hospitals
Clinics
Diagnostic Laboratories
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Phase Marker companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Phase Marker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Tumor Markers
1.2.3 Cardiac Markers
1.2.4 Thyroid Markers
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Phase Marker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Diagnostic Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chronic Phase Marker Market Perspective (2019-2030)
2.2 Chronic Phase Marker Growth Trends by Region
2.2.1 Global Chronic Phase Marker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Chronic Phase Marker Historic Market Size by Region (2019-2024)
2.2.3 Chronic Phase Marker Forecasted Market Size by Region (2025-2030)
2.3 Chronic Phase Marker Market Dynamics
2.3.1 Chronic Phase Marker Industry Trends
2.3.2 Chronic Phase Marker Market Drivers
2.3.3 Chronic Phase Marker Market Challenges
2.3.4 Chronic Phase Marker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Phase Marker Players by Revenue
3.1.1 Global Top Chronic Phase Marker Players by Revenue (2019-2024)
3.1.2 Global Chronic Phase Marker Revenue Market Share by Players (2019-2024)
3.2 Global Chronic Phase Marker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Phase Marker Revenue
3.4 Global Chronic Phase Marker Market Concentration Ratio
3.4.1 Global Chronic Phase Marker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Phase Marker Revenue in 2023
3.5 Chronic Phase Marker Key Players Head office and Area Served
3.6 Key Players Chronic Phase Marker Product Solution and Service
3.7 Date of Enter into Chronic Phase Marker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Phase Marker Breakdown Data by Type
4.1 Global Chronic Phase Marker Historic Market Size by Type (2019-2024)
4.2 Global Chronic Phase Marker Forecasted Market Size by Type (2025-2030)
5 Chronic Phase Marker Breakdown Data by Application
5.1 Global Chronic Phase Marker Historic Market Size by Application (2019-2024)
5.2 Global Chronic Phase Marker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Chronic Phase Marker Market Size (2019-2030)
6.2 North America Chronic Phase Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Chronic Phase Marker Market Size by Country (2019-2024)
6.4 North America Chronic Phase Marker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chronic Phase Marker Market Size (2019-2030)
7.2 Europe Chronic Phase Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Chronic Phase Marker Market Size by Country (2019-2024)
7.4 Europe Chronic Phase Marker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Phase Marker Market Size (2019-2030)
8.2 Asia-Pacific Chronic Phase Marker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Chronic Phase Marker Market Size by Region (2019-2024)
8.4 Asia-Pacific Chronic Phase Marker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chronic Phase Marker Market Size (2019-2030)
9.2 Latin America Chronic Phase Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Chronic Phase Marker Market Size by Country (2019-2024)
9.4 Latin America Chronic Phase Marker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Phase Marker Market Size (2019-2030)
10.2 Middle East & Africa Chronic Phase Marker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Chronic Phase Marker Market Size by Country (2019-2024)
10.4 Middle East & Africa Chronic Phase Marker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nordic BioSite
11.1.1 Nordic BioSite Company Detail
11.1.2 Nordic BioSite Business Overview
11.1.3 Nordic BioSite Chronic Phase Marker Introduction
11.1.4 Nordic BioSite Revenue in Chronic Phase Marker Business (2019-2024)
11.1.5 Nordic BioSite Recent Development
11.2 DiaSorin
11.2.1 DiaSorin Company Detail
11.2.2 DiaSorin Business Overview
11.2.3 DiaSorin Chronic Phase Marker Introduction
11.2.4 DiaSorin Revenue in Chronic Phase Marker Business (2019-2024)
11.2.5 DiaSorin Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Chronic Phase Marker Introduction
11.3.4 Roche Revenue in Chronic Phase Marker Business (2019-2024)
11.3.5 Roche Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Detail
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Chronic Phase Marker Introduction
11.4.4 Bristol-Myers Squibb Revenue in Chronic Phase Marker Business (2019-2024)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Hologic
11.5.1 Hologic Company Detail
11.5.2 Hologic Business Overview
11.5.3 Hologic Chronic Phase Marker Introduction
11.5.4 Hologic Revenue in Chronic Phase Marker Business (2019-2024)
11.5.5 Hologic Recent Development
11.6 QIAGEN
11.6.1 QIAGEN Company Detail
11.6.2 QIAGEN Business Overview
11.6.3 QIAGEN Chronic Phase Marker Introduction
11.6.4 QIAGEN Revenue in Chronic Phase Marker Business (2019-2024)
11.6.5 QIAGEN Recent Development
11.7 Philips
11.7.1 Philips Company Detail
11.7.2 Philips Business Overview
11.7.3 Philips Chronic Phase Marker Introduction
11.7.4 Philips Revenue in Chronic Phase Marker Business (2019-2024)
11.7.5 Philips Recent Development
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Detail
11.8.2 Johnson & Johnson Business Overview
11.8.3 Johnson & Johnson Chronic Phase Marker Introduction
11.8.4 Johnson & Johnson Revenue in Chronic Phase Marker Business (2019-2024)
11.8.5 Johnson & Johnson Recent Development
11.9 Lifesign
11.9.1 Lifesign Company Detail
11.9.2 Lifesign Business Overview
11.9.3 Lifesign Chronic Phase Marker Introduction
11.9.4 Lifesign Revenue in Chronic Phase Marker Business (2019-2024)
11.9.5 Lifesign Recent Development
11.10 Natus
11.10.1 Natus Company Detail
11.10.2 Natus Business Overview
11.10.3 Natus Chronic Phase Marker Introduction
11.10.4 Natus Revenue in Chronic Phase Marker Business (2019-2024)
11.10.5 Natus Recent Development
11.11 BrainScope
11.11.1 BrainScope Company Detail
11.11.2 BrainScope Business Overview
11.11.3 BrainScope Chronic Phase Marker Introduction
11.11.4 BrainScope Revenue in Chronic Phase Marker Business (2019-2024)
11.11.5 BrainScope Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Chronic Phase Marker Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Tumor Markers
Table 3. Key Players of Cardiac Markers
Table 4. Key Players of Thyroid Markers
Table 5. Key Players of Others
Table 6. Global Chronic Phase Marker Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Chronic Phase Marker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Chronic Phase Marker Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Chronic Phase Marker Market Share by Region (2019-2024)
Table 10. Global Chronic Phase Marker Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Chronic Phase Marker Market Share by Region (2025-2030)
Table 12. Chronic Phase Marker Market Trends
Table 13. Chronic Phase Marker Market Drivers
Table 14. Chronic Phase Marker Market Challenges
Table 15. Chronic Phase Marker Market Restraints
Table 16. Global Chronic Phase Marker Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Chronic Phase Marker Market Share by Players (2019-2024)
Table 18. Global Top Chronic Phase Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Phase Marker as of 2023)
Table 19. Ranking of Global Top Chronic Phase Marker Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Chronic Phase Marker Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Phase Marker Product Solution and Service
Table 23. Date of Enter into Chronic Phase Marker Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Phase Marker Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Chronic Phase Marker Revenue Market Share by Type (2019-2024)
Table 27. Global Chronic Phase Marker Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Chronic Phase Marker Revenue Market Share by Type (2025-2030)
Table 29. Global Chronic Phase Marker Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Chronic Phase Marker Revenue Market Share by Application (2019-2024)
Table 31. Global Chronic Phase Marker Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Chronic Phase Marker Revenue Market Share by Application (2025-2030)
Table 33. North America Chronic Phase Marker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Chronic Phase Marker Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Chronic Phase Marker Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Chronic Phase Marker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Chronic Phase Marker Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Chronic Phase Marker Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Chronic Phase Marker Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Chronic Phase Marker Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Chronic Phase Marker Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Chronic Phase Marker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Chronic Phase Marker Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Chronic Phase Marker Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Chronic Phase Marker Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Chronic Phase Marker Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Chronic Phase Marker Market Size by Country (2025-2030) & (US$ Million)
Table 48. Nordic BioSite Company Detail
Table 49. Nordic BioSite Business Overview
Table 50. Nordic BioSite Chronic Phase Marker Product
Table 51. Nordic BioSite Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 52. Nordic BioSite Recent Development
Table 53. DiaSorin Company Detail
Table 54. DiaSorin Business Overview
Table 55. DiaSorin Chronic Phase Marker Product
Table 56. DiaSorin Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 57. DiaSorin Recent Development
Table 58. Roche Company Detail
Table 59. Roche Business Overview
Table 60. Roche Chronic Phase Marker Product
Table 61. Roche Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 62. Roche Recent Development
Table 63. Bristol-Myers Squibb Company Detail
Table 64. Bristol-Myers Squibb Business Overview
Table 65. Bristol-Myers Squibb Chronic Phase Marker Product
Table 66. Bristol-Myers Squibb Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 67. Bristol-Myers Squibb Recent Development
Table 68. Hologic Company Detail
Table 69. Hologic Business Overview
Table 70. Hologic Chronic Phase Marker Product
Table 71. Hologic Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 72. Hologic Recent Development
Table 73. QIAGEN Company Detail
Table 74. QIAGEN Business Overview
Table 75. QIAGEN Chronic Phase Marker Product
Table 76. QIAGEN Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 77. QIAGEN Recent Development
Table 78. Philips Company Detail
Table 79. Philips Business Overview
Table 80. Philips Chronic Phase Marker Product
Table 81. Philips Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 82. Philips Recent Development
Table 83. Johnson & Johnson Company Detail
Table 84. Johnson & Johnson Business Overview
Table 85. Johnson & Johnson Chronic Phase Marker Product
Table 86. Johnson & Johnson Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 87. Johnson & Johnson Recent Development
Table 88. Lifesign Company Detail
Table 89. Lifesign Business Overview
Table 90. Lifesign Chronic Phase Marker Product
Table 91. Lifesign Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 92. Lifesign Recent Development
Table 93. Natus Company Detail
Table 94. Natus Business Overview
Table 95. Natus Chronic Phase Marker Product
Table 96. Natus Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 97. Natus Recent Development
Table 98. BrainScope Company Detail
Table 99. BrainScope Business Overview
Table 100. BrainScope Chronic Phase Marker Product
Table 101. BrainScope Revenue in Chronic Phase Marker Business (2019-2024) & (US$ Million)
Table 102. BrainScope Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Phase Marker Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Chronic Phase Marker Market Share by Type: 2023 VS 2030
Figure 3. Tumor Markers Features
Figure 4. Cardiac Markers Features
Figure 5. Thyroid Markers Features
Figure 6. Others Features
Figure 7. Global Chronic Phase Marker Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Chronic Phase Marker Market Share by Application: 2023 VS 2030
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Diagnostic Laboratories Case Studies
Figure 12. Chronic Phase Marker Report Years Considered
Figure 13. Global Chronic Phase Marker Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global Chronic Phase Marker Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Chronic Phase Marker Market Share by Region: 2023 VS 2030
Figure 16. Global Chronic Phase Marker Market Share by Players in 2023
Figure 17. Global Top Chronic Phase Marker Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Phase Marker as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by Chronic Phase Marker Revenue in 2023
Figure 19. North America Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America Chronic Phase Marker Market Share by Country (2019-2030)
Figure 21. United States Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Chronic Phase Marker Market Share by Country (2019-2030)
Figure 25. Germany Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Chronic Phase Marker Market Share by Region (2019-2030)
Figure 33. China Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Chronic Phase Marker Market Share by Country (2019-2030)
Figure 41. Mexico Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Chronic Phase Marker Market Share by Country (2019-2030)
Figure 45. Turkey Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia Chronic Phase Marker Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Nordic BioSite Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 48. DiaSorin Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 49. Roche Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 50. Bristol-Myers Squibb Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 51. Hologic Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 52. QIAGEN Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 53. Philips Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 54. Johnson & Johnson Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 55. Lifesign Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 56. Natus Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 57. BrainScope Revenue Growth Rate in Chronic Phase Marker Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
